Literature DB >> 7499256

Ligand binding characteristics of the carboxyl-terminal domain of the cytokine receptor homologous region of the granulocyte colony-stimulating factor receptor.

H Anaguchi1, O Hiraoka, K Yamasaki, S Naito, Y Ota.   

Abstract

The carboxyl-terminal domain (BC domain, roughly 100 amino acid residues) of the cytokine receptor homologous region in the receptor for murine granulocyte colony-stimulating factor was secreted as a maltose binding protein fusion into the Escherichia coli periplasm. The murine BC domain was prepared from the fusion protein by restriction protease factor Xa digestion and was purified to homogeneity. The purified BC domain specifically and stoichiometrically bound granulocyte colony-stimulating factor. This result indicates that the BC domain is also critical for ligand binding, as shown for the amino-terminal domain of the cytokine receptor homologous region (Hiraoka, O., Anaguchi, H., Yamasaki, K., Fukunaga, R., Nagata, S., and Ota, Y. (1994) J. Biol. Chem. 269, 22412-22419). The tertiary folding and the beta-sheet structure of the BC domain were confirmed by NMR spectroscopy. The disulfide bond pattern suggested from peptide mapping was Cys224-Cys271 and Cys242-Cys285. Disruption of the disulfide bonds suggested that both bonds are critical for maintaining the folding of the BC domain, although a BC domain lacking the second bond still retained ligand binding activity. Mutational analysis of the WSXWS sequence conserved in the cytokine receptor family suggested that this motif is critical for protein folding rather than for ligand binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499256     DOI: 10.1074/jbc.270.46.27845

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  A biosensor study indicating that entropy, electrostatics, and receptor glycosylation drive the binding interaction between interleukin-7 and its receptor.

Authors:  Scott T R Walsh
Journal:  Biochemistry       Date:  2010-09-15       Impact factor: 3.162

2.  Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.

Authors:  A C Ward; Y M van Aesch; J Gits; A M Schelen; J P de Koning; D van Leeuwen; M H Freedman; I P Touw
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

3.  Divergent pathways in COS-7 cells mediate defective internalization and intracellular routing of truncated G-CSFR forms in SCN/AML.

Authors:  Melissa G Hunter; Morgan McLemore; Daniel C Link; Megan Loveland; Alexander Copelan; Belinda R Avalos
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.